Posted on May 25, 2021
Our partners, GenesisCare, now offer Theranostics here at Waratah Private. This evolving approach to cancer management combines diagnostic imaging and radionuclide therapy. To date, Theranostics has been most successfully used for metastatic castrate-resistant prostate cancer and advanced neuroendocrine tumours (NETs). Theranostics may also be an option for metastatic disease unresponsive to or unsuitable for conventional therapies. Access for these patients is via the TGA Special Access Scheme.
Contact theranosticsreception@genesiscare.com for further information about this treatment.
Filed under: Waratah News
The first Friday of March each year marks a significant day where employers celebrate their greatest asset, their amazing people! Across Evolution, we are proud to celebrate...
We’re wishing every woman across Evolution a very happy International Women’s Day! Across our Group we have over 450 women (over 84%) who continually strive to provide...
Today is National Anaesthetic Technician Day and we are celebrating the many amazing and wonderful Anaesthetic Technicians and Registered Nurse Anaesthetic Assistants across our Group! Anaesthetic Technicians...
We know cataracts are a leading cause of vision impairment, and timely attention is vital to restore sight and quality of life. If you have patients currently...